课题基金 / 基金详情

Identification of androgen-response genes related with the proliferation and development of proliferation-related marker in prostate cancer

Identification of androgen-response genes related with the proliferation and development of proliferation-related marker in prostate cancer
前列腺癌中与增殖相关的雄激素反应基因和增殖相关标志物的发育的鉴定
批准号:
21592037
负责人:
MIZOKAMI Atsushi
金额:
$2.91万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2009
资助国家:
日本
项目状态:
已结题
起止时间:
2009 至 2011

项目摘要

项目成果

MIZOKAMI Atsushi的其他基金

相似基金

相关文献

中文摘要
翻译
我们试图鉴定影响前列腺癌增殖的基因中雄激素受体的敏感性。我们用正常组织与前列腺穿刺活检获得的前列腺癌组织的基因表达谱进行了比较。然后我们关注CAMKK2在癌症患者中这些基因的表达增加了大约6倍。在雄激素敏感的前列腺癌细胞LNCaP中,DHT诱导CAMKK2表达。在前列腺组织免疫组化染色和体外研究中,CAMKK2作为抗原基因发挥作用。
英文摘要
We tried identification to affect the androgen receptor sensitivity in the gene which affected the proliferation of the prostate cancer. We compared a gene expression profile by cDNA microarray which we used a normal tissue for with the prostate cancer tissue by several obtained by prostatic needle biopsy. Then we focused on CAMKK2 which the approximately 6 times expression enhanced in patients with cancer in those genes. As for CAMKK2, expression was induced in androgen-sensitive prostate cancer cell line LNCaP by DHT. In immunohistochemical staining of the prostatic tissue and in vitro study, CAMKK2 functioned as antioncogene.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
前立腺癌治療組成物及び前立腺癌治療組成物の有効成分のスクリーニング方法
前列腺癌治疗组合物以及筛选前列腺癌治疗组合物的活性成分的方法
DOI: --
发表时间: 2011
期刊:
影响因子: --
作者: []
通讯作者:
前立腺癌治療組成物及び前立腺癌治療
前列腺癌治疗组合物和前列腺癌治疗
DOI: --
发表时间: 2011
期刊:
影响因子: --
作者: []
通讯作者:
DOI: 10.1002/pros.22533
发表时间: 2012-12
期刊: The Prostate
影响因子: --
作者: [Takashi Shima;A. Mizokami;Toru Miyagi;K. Kawai;K. Izumi;Misako Kumaki;Mitsuo Ofude;Jian Zhang;E. Keller;M. Namiki]
通讯作者: Takashi Shima;A. Mizokami;Toru Miyagi;K. Kawai;K. Izumi;Misako Kumaki;Mitsuo Ofude;Jian Zhang;E. Keller;M. Namiki
Down-regulation of CAMKK2 by androgen deprivation induces castration-resistant prostate cancer
雄激素剥夺导致 CAMKK2 下调诱导去势抵抗性前列腺癌
DOI: --
发表时间: 2012
期刊:
影响因子: --
作者: [Takashi Shima, Atsushi Mizokami, Toru Miyagi, Keiichi Kawai, Kouji Izumi, Misako Kumaki, Zhang Jian, Evan T. Keller, and Mikio Namiki.]
通讯作者: and Mikio Namiki.
The development of the innovative therapeutic drugs which targete crosstalk in the prostate cancer microenvironment
  • 批准号:
    17H04325
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $11.07万
  • 财政年份:
    2017
  • 负责人:
    MIZOKAMI Atsushi
  • 依托单位:
Prevention of CRPC and application for docetaxel treatment using flavonoids
  • 批准号:
    25462472
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.16万
  • 财政年份:
    2013
  • 负责人:
    MIZOKAMI Atsushi
  • 依托单位:
Identification of progression-related genes in prostate cancer and application to treatment
  • 批准号:
    17591669
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.24万
  • 财政年份:
    2005
  • 负责人:
    MIZOKAMI Atsushi
  • 依托单位:
Effect of cyclooxygenase-2 and lipoxygenase on progression of prostate cancer
  • 批准号:
    15591676
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.24万
  • 财政年份:
    2003
  • 负责人:
    MIZOKAMI Atsushi
  • 依托单位:
海外基金